Securities Report – 112th Fiscal Period (2025/04/01 – 2026/03/31)
Key facts
- Securities Report – 112th Fiscal Period (2025/04/01 – 2026/03/31)
- Kokando Co., Ltd. has published its Securities Report for the 112th fiscal period (April 1, 2025 – March 31, 2026). This official document discloses the company's financial performance and management policies, serving as a key information source for investors and market stakeholders.
- Source: PR Times
- Date: June 25, 2026
Direct answer
Kokando Co., Ltd. has published its Securities Report for the 112th fiscal period (April 1, 2025 – March 31, 2026). This official document discloses the company's financial performance and management policies, serving as a key information source for investors and market stakeholders.
- Citation
- Securities Report – 112th Fiscal Period (2025/04/01 – 2026/03/31) (June 25, 2026), PR Times
- Source
- PR Times
- Date
- June 25, 2026
Kokando Co., Ltd. has published its Securities Report for the 112th fiscal period (April 1, 2025 – March 31, 2026). This official document discloses the company's financial performance and management policies, serving as a key information source for investors and market stakeholders.
📋 Article Processing Timeline
- 📰 Published: June 25, 2026 at 19:01
- 🔍 Collected: June 25, 2026 at 16:13
- 🤖 AI Analyzed: June 25, 2026 at 16:19 (6 min after Collected)
Kokando Co., Ltd. Securities Report – 112th Fiscal Period (2025/04/01 – 2026/03/31)
This report is the Securities Report submitted by Kokando Co., Ltd. (hereinafter referred to as "the Company") pursuant to the Financial Instruments and Exchange Act, covering the Company's business performance, financial condition, and management policies for the 112th fiscal period (from April 1, 2025 to March 31, 2026).
The Company's primary business activities include the manufacturing and sales of pharmaceuticals, medical devices, and health foods. Since its establishment, the Company has integrated the knowledge of Kampo medicine with modern scientific technology, striving to develop and supply safe and reliable products.
This report provides detailed disclosures on the Company's financial statements, business overview, future outlook, risk factors, and corporate governance. These materials serve as essential references for shareholders, investors, financial institutions, and other stakeholders in evaluating the Company's corporate value.
Going forward, the Company will continue to maintain transparent information disclosure and strive for sustainable growth and enhancement of corporate value.
This report is the Securities Report submitted by Kokando Co., Ltd. (hereinafter referred to as "the Company") pursuant to the Financial Instruments and Exchange Act, covering the Company's business performance, financial condition, and management policies for the 112th fiscal period (from April 1, 2025 to March 31, 2026).
The Company's primary business activities include the manufacturing and sales of pharmaceuticals, medical devices, and health foods. Since its establishment, the Company has integrated the knowledge of Kampo medicine with modern scientific technology, striving to develop and supply safe and reliable products.
This report provides detailed disclosures on the Company's financial statements, business overview, future outlook, risk factors, and corporate governance. These materials serve as essential references for shareholders, investors, financial institutions, and other stakeholders in evaluating the Company's corporate value.
Going forward, the Company will continue to maintain transparent information disclosure and strive for sustainable growth and enhancement of corporate value.
FAQ
What is the 112th fiscal period for Kokando?
The 112th fiscal period runs from April 1, 2025 to March 31, 2026.
What is the purpose of a securities report?
It is a mandatory disclosure for listed companies to ensure transparency with investors.
What are Kokando's main products?
They manufacture and sell Kampo medicines, OTC and prescription drugs, and health supplements.
Where can I view the report?
Available on Kokando's official IR site or Japan's EDINET system.
Where is Kokando's headquarters located?
The headquarters is in Nihonbashi-Honcho, Chuo-ku, Tokyo.